Action PCRX PACIRA BIOSCIENCES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Pacira BioSciences, Inc.

Actions

PCRX

US6951271005

Temps réel estimé Cboe BZX
Autres places de cotation
 16:47:22 16/05/2024 		Varia. 5j. Varia. 1 janv.
30,77 USD +2,29 % Graphique intraday de Pacira BioSciences, Inc. +2,61 % -9,19 %
08/05 PACIRA BIOSCIENCES, INC. : Needham & Co. maintient sa recommandation à l'achat ZM
07/05 Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
PACIRA BIOSCIENCES, INC. ANNOUNCES PRICING OF $250.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.125% CONVERTIBLE SENIOR NOTES DUE 2029
Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
Pacira BioSciences : 1Q 2024 Earnings Presentation
Pacira: Q1 Earnings Snapshot
Pacira BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 Revenue $167.1M, vs. Street Est of $165.7M
Pacira BioSciences, Inc. announces an Equity Buyback for $150 million worth of its shares.
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
Pacira Biosciences, Inc. Reiterates Earnings Guidance for the Full Year 2024
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
Pacira BioSciences, Inc. authorizes a Buyback Plan.
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Los bancos occidentales advierten de los riesgos del plan de la UE para usar los activos rusos
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
Pacira BioSciences Says US FDA Granted Knee Osteoarthritis Therapy Candidate RMAT Designation
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PCRX
  4. Actualités Pacira BioSciences, Inc.
  5. Autres langues